List view / Grid view
The FDA has approved the cryopreserved formulation of ReNeuron’s human…
The FDA has approved the cryopreserved formulation of ReNeuron’s human retinal progenitor cell (hRPC) therapeutic candidate...
Clavis Pharma ASA, is pleased to announce the appointment of…
11 July 2011 | By Citigate Dewe Rogerson
Clavis Pharma ASA, is pleased to announce the appointment of Nicholas Adams as Chief Business Officer...
For the Development and Commercialisation of Anti-Cancer Agent CP-4126 in…
11 November 2010 | By Citigate Dewe Rogerson
For the Development and Commercialisation of Anti-Cancer Agent CP-4126 in Asia and Rest of the World...
Clavis Pharma ASA announces the appointment of Athos Gianella-Borradori MD…
24 June 2010 | By Citigate Dewe Rogerson
Clavis Pharma ASA announces the appointment of Athos Gianella-Borradori MD as Chief Medical Officer...
